Arca
Skip to content
Tools
Tools

Amebiasis

Drug research and approvals for amebiasis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 1 studies of amebiasis are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 1 approved and 3 open orphan designations naming it.

  • Recruiting worldwide: 1
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 1
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 1 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

14 approved, 16 in phase 2, 1 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Nitazoxanide, Metronidazole, Tinidazole, Quinacrine, Tilbroquinol, Emetine, Broxyquinoline, Clioquinol, Atovaquone, Paromomycin, Chlorquinaldol, Secnidazole, Ornidazole, Nimorazole

Trimetrexate
Phase 2 Dihydrofolate reductase inhibitor
Diloxanide
Phase 2
Arsthinol
Phase 2
Teclozan
Phase 2
Phanquone
Phase 2
Etofamide
Phase 2
Clefamide
Phase 2
Fumagillin
Phase 2
Auranofin
Phase 1 Unknown

FDA Orphan Designations

Approved first, then open designations, newest first
May 17, 2004TindamaxTreatment of intestinal amebiasis and amebic liver abcess caused by E. histolytica in both adults and pediatric patients older than three…Presutti Laboratories, Inc.Approved
Jun 19, 2017MiltefosineTreatment of disseminated amebiasisProfounda, Inc.Designated
Apr 30, 2010AuranofinTreatment of amebiasisCtr for Discovery & Innovation in Parasitic DiseasDesignated
Oct 23, 2001NitazoxanideTreatment for intestinal amebiasisRomark Laboratories, L.C.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.